Kerbside

The recommendations provided in this column are taken from various market sources such as brokers, analysts, dealers and investment strategists, etc. These recommendations may not be backed by strong fundamentals. Therefore we advise readers to use their own discretion before investing in these recommendation [EasyDNNnews:PaidContentStart]

BLOCKBUSTER RETURNS! 

PVR Inox Ltd
BSE Code: 532689
CMP: ₹961.10 

The stars seem to be perfectly aligned for PVR Inox, with a stellar lineup of hits fueling a strong recovery. The Hindi-dubbed version of Pushpa 2 crossed Rs 900 crore, setting the cash registers ringing. This was followed by the success of Chhaava in February, making it the highest-grossing February post-pandemic, with box office collections touching Rs 1,245 crore, as per industry sources. Now, all eyes are on Eid 2025, when the much-anticipated release of Sikander is expected to deliver a big opening, while Hollywood heavyweights like Marvel’s Thunderbolts and First Steps could sustain the momentum. With footfalls surging, PVR Inox is on track to reclaim its pre-Covid operating margins—a level last seen in its heyday. If the box office continues to shine, investors could be in for blockbuster returns in the short term. 

LUBRICATE GAINS! 

Gulf Oil Lubricants India
BSE Code: 538567
CMP: ₹1,259.35 

Gulf Oil Lubricants India Limited (GOLIL), part of the transnational Hinduja Group, continues to fire on all cylinders. The company, which sells lubricants under the Gulf brand, primarily caters to the automotive and industrial sectors. Despite industry headwinds, Q3FY25 was a record-breaking quarter, with the highest-ever quarterly volumes and strong double-digit topline growth. The company remains virtually debt-free and has guided for EBITDA margins between 12-14 per cent for the next two quarters. With attractive valuations providing a margin of safety, this stock offers a compelling buy for investors looking for steady, high-quality growth. 

SKETCH PROFITS 

DOMS
BSE Code: 544045
CMP: ₹2,856.75 

DOMS, a leading name in stationery and art materials, continues to sharpen its edge. A top brokerage house’s research team recently visited its plant, and insiders say they are strongly advocating HNIs to take a bullish stance on the stock. What sets DOMS apart is its full backward integration in core categories like pencils, sketch pens, and mathematical instrument boxes. The company’s innovation drive remains strong, with new products like finger paints, floating markers, and water-based gum showcased on the shop floor. With an expanding product basket (SKUs up from 3,800 to 4,350 YoY) and a growing distribution network (retail touchpoints up from 122,500 to 140,000 YoY), the stock could be set for fireworks in the coming quarters. 

PRESCRIPTION FOR PROFITS 

AstraZeneca Pharma India
BSE Code: 506820
CMP: ₹7,928.65 

AstraZeneca Pharma India is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in four therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory & Immunology and Rare Diseases. Astrazeneca is firing on all cylinders, reporting a stellar 44 per cent revenue surge driven by strong momentum across therapeutic areas.Its innovation-first strategy continues to propel robust growth in India, cementing its position in the sector. A top brokerage’s technical analyst sees double-digit return potential from current levels, making it a compelling pick for investors. With fundamentals and momentum aligned, this pharma stock is a must-have before the next big rally! 

(Closing price as of March 18, 2025) 

[EasyDNNnews:PaidContentEnd] [EasyDNNnews:UnPaidContentStart]

[EasyDNNnews:UnPaidContentEnd]